292 related articles for article (PubMed ID: 16382155)
1. Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation.
Ju W; Ogawa A; Heyer J; Nierhof D; Yu L; Kucherlapati R; Shafritz DA; Böttinger EP
Mol Cell Biol; 2006 Jan; 26(2):654-67. PubMed ID: 16382155
[TBL] [Abstract][Full Text] [Related]
2. Involvement of TGF-β1/Smad3 Signaling in Carbon Tetrachloride-Induced Acute Liver Injury in Mice.
Niu L; Cui X; Qi Y; Xie D; Wu Q; Chen X; Ge J; Liu Z
PLoS One; 2016; 11(5):e0156090. PubMed ID: 27224286
[TBL] [Abstract][Full Text] [Related]
3. Smad2 and Smad3 are redundantly essential for the TGF-beta-mediated regulation of regulatory T plasticity and Th1 development.
Takimoto T; Wakabayashi Y; Sekiya T; Inoue N; Morita R; Ichiyama K; Takahashi R; Asakawa M; Muto G; Mori T; Hasegawa E; Saika S; Hara T; Nomura M; Yoshimura A
J Immunol; 2010 Jul; 185(2):842-55. PubMed ID: 20548029
[TBL] [Abstract][Full Text] [Related]
4. A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling.
Brown KA; Pietenpol JA; Moses HL
J Cell Biochem; 2007 May; 101(1):9-33. PubMed ID: 17340614
[TBL] [Abstract][Full Text] [Related]
5. Signaling via Smad2 and Smad3 is dispensable for adult murine hematopoietic stem cell function in vivo.
Billing M; Rörby E; Dahl M; Blank U; Andradottír S; Ehinger M; Karlsson S
Exp Hematol; 2017 Nov; 55():34-44.e2. PubMed ID: 28666967
[TBL] [Abstract][Full Text] [Related]
6. TSC1 activates TGF-β-Smad2/3 signaling in growth arrest and epithelial-to-mesenchymal transition.
Thien A; Prentzell MT; Holzwarth B; Kläsener K; Kuper I; Boehlke C; Sonntag AG; Ruf S; Maerz L; Nitschke R; Grellscheid SN; Reth M; Walz G; Baumeister R; Neumann-Haefelin E; Thedieck K
Dev Cell; 2015 Mar; 32(5):617-30. PubMed ID: 25727005
[TBL] [Abstract][Full Text] [Related]
7. Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer.
Matsuzaki K; Kitano C; Murata M; Sekimoto G; Yoshida K; Uemura Y; Seki T; Taketani S; Fujisawa J; Okazaki K
Cancer Res; 2009 Jul; 69(13):5321-30. PubMed ID: 19531654
[TBL] [Abstract][Full Text] [Related]
8. Connective tissue growth factor is a Smad2 regulated amplifier of transforming growth factor beta actions in hepatocytes--but without modulating bone morphogenetic protein 7 signaling.
Gressner OA; Lahme B; Siluschek M; Rehbein K; Weiskirchen R; Gressner AM
Hepatology; 2009 Jun; 49(6):2021-30. PubMed ID: 19309720
[TBL] [Abstract][Full Text] [Related]
9. A mediator of phosphorylated Smad2/3, evodiamine, in the reversion of TAF-induced EMT in normal colonic epithelial cells.
Yang W; Gong X; Wang X; Huang C
Invest New Drugs; 2019 Oct; 37(5):865-875. PubMed ID: 30488243
[TBL] [Abstract][Full Text] [Related]
10. Requirement for the SnoN oncoprotein in transforming growth factor beta-induced oncogenic transformation of fibroblast cells.
Zhu Q; Pearson-White S; Luo K
Mol Cell Biol; 2005 Dec; 25(24):10731-44. PubMed ID: 16314499
[TBL] [Abstract][Full Text] [Related]
11. Unique and redundant roles of Smad3 in TGF-beta-mediated regulation of long bone development in organ culture.
Alvarez J; Serra R
Dev Dyn; 2004 Aug; 230(4):685-99. PubMed ID: 15254903
[TBL] [Abstract][Full Text] [Related]
12. Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis.
Petersen M; Pardali E; van der Horst G; Cheung H; van den Hoogen C; van der Pluijm G; Ten Dijke P
Oncogene; 2010 Mar; 29(9):1351-61. PubMed ID: 20010874
[TBL] [Abstract][Full Text] [Related]
13. Maternal Smad3 deficiency compromises decidualization in mice.
Zhao KQ; Lin HY; Zhu C; Yang X; Wang H
J Cell Biochem; 2012 Oct; 113(10):3266-75. PubMed ID: 22644778
[TBL] [Abstract][Full Text] [Related]
14. AMPK Inhibits the Stimulatory Effects of TGF-β on Smad2/3 Activity, Cell Migration, and Epithelial-to-Mesenchymal Transition.
Lin H; Li N; He H; Ying Y; Sunkara S; Luo L; Lv N; Huang D; Luo Z
Mol Pharmacol; 2015 Dec; 88(6):1062-71. PubMed ID: 26424816
[TBL] [Abstract][Full Text] [Related]
15. Implication of Smad2 and Smad3 in transforming growth factor-β-induced posterior capsular opacification of human lens epithelial cells.
Li H; Yuan X; Li J; Tang X
Curr Eye Res; 2015 Apr; 40(4):386-97. PubMed ID: 24911914
[TBL] [Abstract][Full Text] [Related]
16. Identification of the gene transcription and apoptosis mediated by TGF-beta-Smad2/3-Smad4 signaling.
Yu J; Zhang L; Chen A; Xiang G; Wang Y; Wu J; Mitchelson K; Cheng J; Zhou Y
J Cell Physiol; 2008 May; 215(2):422-33. PubMed ID: 17960585
[TBL] [Abstract][Full Text] [Related]
17. The role of Smad3 in mediating mouse hepatic stellate cell activation.
Schnabl B; Kweon YO; Frederick JP; Wang XF; Rippe RA; Brenner DA
Hepatology; 2001 Jul; 34(1):89-100. PubMed ID: 11431738
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of Glt25d1 aggravates carbon tetrachloride‑induced acute hepatic injury through activation of the TGF‑β1/Smad2 signaling pathway.
Ye X; He L; Ma J; Li Y; Zhang M; Yang J; Zhang J; Xiao F; Wei H
Mol Med Rep; 2018 Oct; 18(4):3611-3618. PubMed ID: 30132521
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor β induces expression of connective tissue growth factor in hepatic progenitor cells through Smad independent signaling.
Ding ZY; Jin GN; Liang HF; Wang W; Chen WX; Datta PK; Zhang MZ; Zhang B; Chen XP
Cell Signal; 2013 Oct; 25(10):1981-92. PubMed ID: 23727026
[TBL] [Abstract][Full Text] [Related]
20. Induction by transforming growth factor-beta1 of epithelial to mesenchymal transition is a rare event in vitro.
Brown KA; Aakre ME; Gorska AE; Price JO; Eltom SE; Pietenpol JA; Moses HL
Breast Cancer Res; 2004; 6(3):R215-31. PubMed ID: 15084245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
